Tg Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Tg Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tg Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Tg Therapeutics by Connor, Clark & Lunn Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $5.9M | 346k | 17.08 |
2023-06-30 | $8.1M | 328k | 24.84 |
2021-06-30 | $730k | 19k | 38.80 |
2020-12-31 | $1.3M | 25k | 52.01 |
2020-03-31 | $395k | 40k | 9.85 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management